Clinical Trials Directory

Trials / Terminated

TerminatedNCT00894465

Midazolam Effect in Children Undergoing Voiding Cystourethrogram (VCUG)

A Randomized, Double-Blind, Placebo-Controlled Study Examining the Efficacy of Oral Midazolam in Reducing Anxiety in Children Undergoing Voiding Cystourethrogram

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
44 (actual)
Sponsor
Washington University School of Medicine · Academic / Other
Sex
All
Age
2 Years – 6 Years
Healthy volunteers
Accepted

Summary

The purpose of this research is to validate the common administration of oral midazolam to children prior to voiding cystourethrogram (VCUG) to see if this will significantly decrease children's anxiety and make the experience less traumatic.

Conditions

Interventions

TypeNameDescription
DRUGmidazolamChildren are randomized to receive oral midazolam .5 mg/kg prior to undergoing VCUG
DRUGplaceboChildren are randomized to receive a placebo prior to undergoing VCUG

Timeline

Start date
2006-08-01
Primary completion
2009-06-01
Completion
2009-08-01
First posted
2009-05-07
Last updated
2016-12-09
Results posted
2016-12-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00894465. Inclusion in this directory is not an endorsement.